What is Archimedic?
Archimedic operates as a specialized partner in the medical device industry, providing comprehensive development services that prioritize safety and regulatory compliance. The company distinguishes itself through a rigorous Quality Management System that adheres to 21 CFR 820 FDA Quality System Regulation and ISO 13485:2016 standards. By integrating these high-level compliance frameworks into its core service offering, Archimedic effectively mitigates risk for its clients, ensuring that medical innovations meet the stringent requirements necessary for market entry and clinical efficacy. Its market position is defined by this technical precision and a deep understanding of the intersection between engineering excellence and regulatory oversight.
How much funding has Archimedic raised?
Archimedic has raised a total of $808K across 2 funding rounds:
Debt
$350K
Debt
$458K
Debt (2020): $350K with participation from PPP
Debt (2021): $458K led by PPP
Key Investors in Archimedic
PPP
Public-Private Partnership
What's next for Archimedic?
With the recent infusion of capital, Archimedic is well-positioned to expand its enterprise-level service offerings and further refine its proprietary development methodologies. The strategic focus will likely shift toward enhancing operational capacity to meet the increasing demand for compliant medical device engineering. As the company continues to navigate the complexities of the healthcare technology sector, this financial backing provides the necessary runway to invest in talent acquisition and advanced quality assurance technologies. Future growth will be predicated on maintaining its reputation for excellence while scaling its footprint in a competitive landscape that increasingly values regulatory-ready solutions.
See full Archimedic company page
